Review: Addition of inhaled corticosteroids to long-acting β2-agonists does not improve outcomes in stable COPD

被引：0
|
作者：
Aaron, Shawn D. [1 ]
机构：
[1] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2010年 / 152卷 / 06期
关键词：
D O I：
10.7326/0003-4819-152-6-201003160-02005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Long-Acting β-Agonists (LABA) Combined With Long-Acting Muscarinic Antagonists or LABA Combined With Inhaled Corticosteroids for Patients With Stable COPD
    Horita, Nobuyuki
    Nagashima, Akimichi
    Kaneko, Takeshi
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (13): : 1274 - 1275
  • [22] Long-Acting β2 Agonists and Inhaled Corticosteroids in Asthma
    Lipworth, Brian J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (09) : 853 - 854
  • [23] Lipid peroxides in stable asthmatics receiving inhaled steroids and long-acting β2-agonists
    Alzoghaibi, Mohammed A.
    Bahammam, Ahmed S.
    RESPIROLOGY, 2007, 12 (03) : 439 - 442
  • [24] Burden of illness among patients with asthma prescribed inhaled corticosteroids/long-acting β2-agonists
    Zhang, Shiyuan
    Czira, Alexandrosz
    Harley, Julia
    Rothnie, Kieran J.
    Lee, Lauren
    Small, Mark
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2025, 35 (01)
  • [25] Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
    Sousa-Pinto, B.
    Louis, R.
    Anto, J. M.
    Amaral, R.
    Sa-Sousa, A.
    Czarlewski, W.
    Brussino, L.
    Canonica, G. W.
    Chaves Loureiro, C.
    Cruz, A. A.
    Gemicioglu, B.
    Haahtela, T.
    Kupczyk, M.
    Kvedariene, V.
    Larenas-Linnemann, D. E.
    Okamoto, Y.
    Ollert, M.
    Pfaar, O.
    Pham-Thi, N.
    Puggioni, F.
    Regateiro, F. S.
    Romantowski, J.
    Sastre, J.
    Scichilone, N.
    Taborda-Barata, L.
    Ventura, M. T.
    Agache, I.
    Bedbrook, A.
    Becker, S.
    Bergmann, K. C.
    Bosnic-Anticevich, S.
    Bonini, M.
    Boulet, L. -P.
    Brusselle, G.
    Buhl, R.
    Cecchi, L.
    Charpin, D.
    de Blay, F.
    Del Giacco, S.
    Ivancevich, J. C.
    Jutel, M.
    Klimek, L.
    Kraxner, H.
    Kuna, P.
    Laune, D.
    Makela, M.
    Morais-Almeida, M.
    Nadif, R.
    Niedoszytko, M.
    Papadopoulos, N. G.
    PULMONOLOGY, 2025, 31 (01):
  • [26] Combination long-acting β2-agonists and inhaled corticosteroids in chronic obstructive pulmonary disease -: In response
    Vestbo, J
    CLINICAL MEDICINE, 2004, 4 (05) : 470 - 470
  • [27] Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics
    Caminati, Marco
    Vianello, Andrea
    Andretta, Margherita
    Menti, Anna Michela
    Tognella, Silvia
    Esposti, Luca Degli
    Micheletto, Claudio
    Bovo, Chiara
    Senna, Gianenrico
    ERJ OPEN RESEARCH, 2020, 6 (02)
  • [28] The addition of long-acting beta-agonists to inhaled corticosteroids in asthma
    Sears, Malcolm R.
    CURRENT OPINION IN PULMONARY MEDICINE, 2011, 17 (01) : 23 - 28
  • [29] Long-acting inhaled β2-agonists and the loss of "bronchoprotective" efficacy
    Abisheganaden, J
    Boushey, HA
    AMERICAN JOURNAL OF MEDICINE, 1998, 104 (05): : 494 - 497
  • [30] Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β2-Agonists in Achieving Asthma Control
    O'Byrne, Paul M.
    Naya, Ian P.
    Kallen, Anders
    Postma, Dirkje S.
    Barnes, Peter J.
    CHEST, 2008, 134 (06) : 1192 - 1199
12345